Defining Natural History: Assessment of the Ability of College Students to Aid in Characterizing Clinical Progression of Niemann-Pick Disease, Type C by Shin, Jenny et al.
Defining Natural History: Assessment of the Ability of
College Students to Aid in Characterizing Clinical
Progression of Niemann-Pick Disease, Type C
Jenny Shin
1., Katrina Epperson
1., Nicole M. Yanjanin
2, Jennifer Albus
3, Laura Borgenheimer
3, Natalie
Bott
3, Erin Brennan
3, Daniel Castellanos
3, Melissa Cheng
3, Michael Clark
3, Margaret Devany
3, Courtney
Ensslin
3, Nina Farivari
3, Shanik Fernando
3, Lauren Gabriel
3, Rani Gallardo
3, Moriah Castleman
3, Olimpia
Gutierrez
3, Allison Herschel
3, Sarah Hodge
3, Anne Horst
3, Mary Howard
3, Evan James
3, Lindsey Jones
3,
Mary Kearns
3, Mary Kelly
3, Christine Kim
3, Kinzie Kiser
3, Gregory Klazura
3, Chris Knoedler
3, Emily
Kolbus
3, Lauren Lange
3, Joan Lee
3, Eileena Li
3, Wei Lu
3, Andrew Luttrell
3, Emily Ly
3, Katherine
McKeough
3, Brianna McSorley
3, Catherine Miller
3, Sean Mitchell
3, Abbey Moon
3, Kevin Moser
3, Shane
O’Brien
3, Paula Olivieri
3, Aaron Patzwahl
3, Marie Pereira
3, Craig Pymento
3, Erin Ramelb
3, Bryce Ramos
3,
Teresa Raya
3, Stephen Riney
3, Geoff Roberts
3, Mark Robertshaw
3, Frannie Rudolf
3, Samuel Rund
3,
Stephanie Sansone
3, Lindsay Schwartz
3, Ryan Shay
3, Edwin Siu
3, Timothy Spear
3, Catherine Tan
3,
Marisa Truong
3, Mairaj Uddin
3, Jennifer VanTrieste
3, Omar Veloz
3, Elizabeth White
3, Forbes D. Porter
2,
Kasturi Haldar
1*
1Center for Rare and Neglected Diseases, University of Notre Dame, Notre Dame, Indiana, United States of America, 2Program in Developmental Endocrinology and
Genetics, NICHD, National Institutes of Health, DHHS, Bethesda, Maryland, United States of America, 3NPC Consortium for Community-Based Assessment of Patient
Records, Cape Town, South Africa
Abstract
Niemann-Pick Disease, type C (NPC) is a fatal, neurodegenerative, lysosomal storage disorder. It is a rare disease with broad
phenotypic spectrum and variable age of onset. These issues make it difficult to develop a universally accepted clinical
outcome measure to assess urgently needed therapies. To this end, clinical investigators have defined emerging, disease
severity scales. The average time from initial symptom to diagnosis is approximately 4 years. Further, some patients may not
travel to specialized clinical centers even after diagnosis. We were therefore interested in investigating whether
appropriately trained, community-based assessment of patient records could assist in defining disease progression using
clinical severity scores. In this study we evolved a secure, step wise process to show that pre-existing medical records may
be correctly assessed by non-clinical practitioners trained to quantify disease progression. Sixty-four undergraduate
students at the University of Notre Dame were expertly trained in clinical disease assessment and recognition of major and
minor symptoms of NPC. Seven clinical records, randomly selected from a total of thirty seven used to establish a leading
clinical severity scale, were correctly assessed to show expected characteristics of linear disease progression. Student
assessment of two new records donated by NPC families to our study also revealed linear progression of disease, but both
showed accelerated disease progression, relative to the current severity scale, especially at the later stages. Together, these
data suggest that college students may be trained in assessment of patient records, and thus provide insight into the
natural history of a disease.
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Introduction
Niemann-Pick Disease, type C (NPC) is a lysosomal, cholesterol
storage disorder [1]. It is an autosomal, recessive, rare disease with
a prevalence in the range of 1:120,000 to 150,000 [2]. Although
the earliest manifestations are splenomegaly and hepatomegaly,
clinically, it presents as a broad spectrum of neurological
problems. This in conjunction with highly variable age of onset
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e23666(ranging from fetal to adult) makes it difficult to diagnose [3, also
reviewed in 2]. Indeed, the average time from initial symptom to
diagnosis is approximately 4 years. Even after diagnosis, which
comprises of a skin biopsy to obtain fibroblasts to demonstrate
accumulation of unesterified cholesterol or genetic testing, there is
need for a universally accepted clinical outcome measure for
testing urgently needed new therapeutics as well as disease
management. Clinical investigators have defined emerging, disease
severity scales [4,5], the most comprehensive of which was recently
reported by Yanjanin et al., 2010 [6], as part of a natural history
study being conducted at the National Institutes of Health (NIH).
However, since the incidence of NPC is low, the number of
patients seen in a clinical center is limited. Many patients will not
travel to specialized clinical centers (even a national center like the
NIH) after diagnosis, because of the paucity of therapies, lack of
information about programs, as well as significant logistical issues.
In addition to enrolling 18 patients on the current study, Yanjanin
et al. [6] were also able to utilize 19 clinical records archived at the
NIH, and this led to the suggestion that assessment of patient
records donated by families including records of patients who have
died from the disease, may be used to rapidly strengthen emerging
clinical severity scales.
For a rare disease like NPC, scales derived from a larger set of
clinical records would represent a significant advance in capturing
a standardized clinical outcome measure. However due to limited
resources associated with rare disease research, only a number of
physicians specialize in NPC, suggesting that community-based
assessment of clinical records by trained volunteers could greatly
facilitate generation of disease severity scales and other clinical
tools. As a first step towards this goal we undertook to develop a
scalable model in which pre-existing medical records may be
correctly assessed by non clinical practitioners trained to quantify
disease progression and assemble succinct clinical summaries. If
successful, this model could be implemented to assist in the
collection of natural history data for other rare diseases.
Methods
Ethics statement
The study was an extension of a Natural History study
performed at the National Institutes of Health in Bethesda,
Maryland. It was approved by the University of Notre Dame
Institutional Review Board (09-174), as well as the Eunice
Kennedy Shriver National Institute of Child Health and Human
Development Institutional Review Board (06-CH-0186,
NCT00344331). Consent and if appropriate assent, were obtained
from guardians and patients. All students received HIPAA training
in class, prior to reviewing private patient data.
Participants and procedures
The study was developed to ascertain whether non-clinical
practitioners who were trained over a few weeks to recognize NPC
clinical disease, could extract clinical severity scores from patient
records. The clinical severity scale of Yanjanin et al. 2010 [6] was
adopted. This scale has been validated with data from 37 patient
records. 18 of these records were from a cross sectional study of
current NPC patients. An additional 19 were obtained from
longitudinal chart review of a ‘historic’ cohort at the NIH, and
thus the scale is expected to be useful as a long-term outcome
measure for biomarkers and therapeutic trials. The scale utilizes
nine major and eight minor clinical symptomatic domains, with a
Likert-like scale to assign scores of 0-5 and 0-2 in each domain-
type respectively. The total scores can range from 0 to 61 and
higher scores indicate increased disease burden.
Training of students was done in an in-class room setting
because this is an easily scalable format. The class, entitled
Developing Health Networks in Rare and Neglected Diseases was
developed by the Center for Rare and Neglected Diseases (CRND)
at the University of Notre Dame in collaboration with the Eunice
Kennedy Shriver National Institute of Child Health and Human
Development (NICHD) and consultation with the Center for
Social Concerns at the University of Notre Dame, Riley Children’s
Hospital, the National Niemann Pick Disease Foundation
(NNPDF), the Ara Parseghian Medical Research Foundation
(APMRF) and the Niemann-Pick Disease Group (UK).
5-30 students were enrolled per class for four classes in Spring
2009, Fall 2009, Spring 2010 and Spring 2011. Registration
required the instructor’s permission (the class was restricted to
upper level undergraduate students). For the initial class in Spring
2009 two graduate students were also allowed to enroll to
determine whether the course was better suited to post graduate
rather than undergraduate students A total of sixty four
undergraduates and two graduate students were enrolled over
the indicated semesters. The class met once a week for 3 contact
hours.
All students registered for the course indicated no prior
experience in clinical research. Thus, for all students, this class
represented the first exposure to critical concepts pertinent for
developing therapies for rare and neglected diseases in general and
specifically Niemann-Pick type C. Students researched multiple
NPC family narratives publicly available via the internet, to
understand the socioeconomic and cultural impact of NPC
disease. Students were then instructed on NPC diagnosis,
symptoms and clinical history through a combination of didactic
lectures and reading of clinical research papers, as well as
discussions with clinical practitioners and researchers in NPC
disease (http://nd.edu/ ˜crnd/CTSSeriesAnnouncements.html).
In Spring 2009, five students (3 undergraduate and 2 graduate
students) were assigned a single clinical history previously assessed
by Yanjanin et al., 2010 [6]. In Fall and Spring 2010, the class size
was expanded to 16 students and an additional three clinical
histories from Yanjanin et al. [6] were also assessed by students
working in teams of four. In Spring 2011, each of these four
clinical histories as well as three additional histories taken from
Yanjanin et al., 2010 [6] were assessed in groups of six students
scoring in pairs, creating triplicate values for each case. This was
done to directly determine the variability in disease severity
assessments ascribed to a medical history, when conducted by a
pairs of students in the same class environment. In Spring 2011,
we also tested the variability in disease severity assessments across
30 students when each student independently assessed disease
severity for a new case directly donated to our study. In all
semesters, a single clinical visit was first assessed in class to confirm
that the logistics of scoring was uniformly understood by the
group. Students then scored the entire clinical history as a take
home exercise to generate individual disease severity curves. In
Spring 2009, Fall 2009 and Spring 2010, the disease severity
curves were subsequently reviewed and finalized in consultation
with clinical experts pediatric nurse practitioner Nicole M.
Yanjanin and physician-scientist Forbes D. Porter from the
intramural research program of Eugene Kennedy Shriver
National Institute of Child Health and Human Development
(NICHD). The indicated disease severity curves incorporated the
concept of the ‘carry-over’ effect which is based on the principle
that increased score for a symptomatic domain in a prior visit is
‘carried’ through to a subsequent clinical visit in absence of any
additional information pertaining to the domain. Thus if a patient
is wheel chair dependent on one visit, this is assumed to be true in
College Students’ Ability to Assess NPC Cases
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‘carry-over’ effect was discussed prior to the visits for Yanjanin and
Porter in order to incorporate it as a standard feature of ‘in class’
training. The overall work flow is summarized in Figure 1.
NPC families were made aware of the study at the 2009 and
2010 NNPDF family meetings in Seattle, Washington and
Toronto, Canada, respectively. Consenting families submitted
records through NNPDF to the NIHCD team. An amendment
was made to the existing protocol, which then allowed for the
records to be forwarded from the NIHCD to the CRND at the
University of Notre Dame.
Results
Early discussions (in Fall 2008) with major stakeholders in the
NPC disease community including, foundations, clinical practi-
tioners and families, led to the concept that direct interactions
between students and patient groups may fail to protect
vulnerabilities of both groups. However, assessment of disease
from clinical records by appropriately trained students and
collaboration with clinical practitioners was likely to offer a secure
process of engagement, training and research.
Comprehensive training of students in clinical NPC disease
manifestation, diagnosis and management and requisite medical
terminology required 4 weeks of a 12 week semester, with three
hours of in-class time and three to six hours of out-of-class time per
week. Followed by one, three hour in-class training session focused
on a single clinical visit from one record, all assessments were
carried out independently by students as part of ‘take-home’
exercises. The first specific product generated by the class was a list
of medical terminology used to describe major and minor
symptomatic domains (Table 1). This assisted understanding and
recognition of symptoms by the students. This list was additionally
expanded to include clinical terms encountered in patient histories
received over four semesters and has evolved as a key, starting
reference tool (Table S1) in assessing new clinical records.
Scoring and disease severity curve generated from NPC
patient records obtained from Yanjanin et al., 2010 [6]
The first class in Spring of 2009 was limited to five students,
three senior undergraduate students who were also Science majors
as well as two graduate students in Biological Sciences. The group
assessed one medical history. The small group size and close
supervision was deemed appropriate since this type of class on
clinical research had not previously been offered for undergrad-
uate students. Five independent disease severity curves were
extracted from a single clinical history. As shown in Figure 2A,
there was close correspondence between student assessments. For
any given symptomatic domain the differences in scores assigned
were no greater than 1 (not shown). The indicated disease severity
curves incorporated of the concept of ‘carry-over’ (see Methods)
The average curve and mean progression score were overlayed on
the data of Yanjanin et al. 2010 [6] (Fig. 2B and C). The rate of
change for this patient, 1.315 closely corresponds to 1.3 previously
reported by Yanjanin et al., 2010 [6].
These data tentatively suggested that upper level undergraduate
college students could be trained to recognize disease domains in
clinical records and compute disease severity scores. Our
impression was that there was no difference in the work product
of undergraduate and graduate students. This justified opening
subsequent class enrollment to undergraduate juniors and seniors
who were declared as Premedical (also referred to as Pre-
Professional) and/or majors in Biological Sciences, Chemistry or
Biochemistry, and thus an expansion in class size.
With a larger class, we adopted group-wise assessment of clinical
records, to minimize operator variability. Thus in Fall 2009 and
Spring 2010, when the class sizes were expanded to 14-16, four
groups of three to five students were assigned the same clinical
record assessed by the initialclass as well as three additional medical
histories from Yanjanin et al. 2010 [6], for assessment. As shown in
Fig. 3A, for a given case, the variation to the mean was comparable
across data points in disease progression curves. These data
suggested that over two semesters, junior and senior undergraduate
students with basic (200 level) background course work in life
sciences, could be sufficiently trained in recognition and quantifi-
cation of disease domains and work in groups of 3–5 to generate
consistent disease progression curves from clinical histories.
Since our long term goal is to maximize the capacity of student
assessment, in the subsequent semester we increased the class
enrollment from 16 to 30. We also investigated the assessment of
records by pairs of students. A single case was assigned to three
pairs of students within a ‘group’ to rigorously assess variation
between pairs within a single class. Of the seven assigned cases,
four had been reviewed by the prior classes. The slopes of the
disease severity scales in Spring 2011 (Fig. 3B) were comparable to
those seen in prior semesters (Fig. 3A), with an average of ,15%
Figure 1. Overall work flow undertaken to assess the ability of college students to assist in characterizing clinical progression of
Niemann Pick Type C. The project began in Fall 2008 with discussions with the Center for Social Concerns at the University of Notre Dame, Riley
Children’s Hospital, Indianapolis, the National Niemann Pick Disease Foundation (NNPDF), the Ara Parseghian Medical Research Foundation (APMRF)
and the Niemann-Pick Disease Group (UK), clinical practitioners at Eunice Kennedy Shriver National Institute of Child Health and Human Development
(NICHD) and faculty and program staff the Center for Rare and Neglected Diseases (CRND) at the University of Notre Dame.
doi:10.1371/journal.pone.0023666.g001
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the variation along disease severity curve for one case [6] was
indeed low (Fig. 3B). This case was not reported in Yanjanin et al.
2010 [6]. However it was partially scored (one visit) before being
transferred to the study and is therefore included. In two records
(numbered cases 7 and 5) we noticed a significant variation across
the triplicates pairs (Fig. 3B; see also Fig. S1). Discussion with the
class suggested that for case 7, fine motor (2-4) and cognition (1-4)
were the areas of greatest variance. Importantly at one age (29),
one group scored consistently higher than the other group in fine
Table 1. NP-C terms students must know.
Ambulation To walk from place to place; move about.
Auditory Brainstem Response An electrical output in response to sound, a response to a complex signal.
Biomarkers A single characteristic that is indicative of a disease.
Cerebellar Ataxia Gross lack of coordination
Cognition The mental process of knowing, including aspects such as awareness, perception, reasoning, and judgment.
Cross-sectional Taken only once
Dysarthria Motor speech disorder
Dysmetria Lack of coordination of movement typified by the undershoot and/or overshoot of intended position with the
hand, arm, leg, or eye. It is sometimes described as an inability to judge distance or scale.
Dysphagia Difficulty swallowing
Dystonia Sustained muscle contractions cause twisting and repetitive movements or abnormal postures.
Fine Motor Skills Coordination of small muscle movements
Gelastic Cataplexy Loosening of the muscle, dropping of the jaw during extreme emotion, such as laughter.
Hyperlipidemia, Type IV A not uncommon inherited metabolic disorder that is characterized by increased blood levels of the
triglyceride form of fat that makes up very low-density lipids (VLDL). Abnormally high blood levels of
triglycerides or cholesterol may be the result of poor dietary habits, genetic causes, or other metabolic
disorders or a side effect of certain drugs. Also known as:
Carbohydrate-Induced Hyperlipemia
Hypercholesterolemia, Type IV
Hyperlipidemia IV
Hyperprebeta-Lipoproteinemia
Hypertriglyceridemia, Endogenous
Hyperreflexia Overactive reflex
Incontinence The inability of organs to restrain the natural evacuations, so that the discharges are involuntary; as,
incontinence of urine. The involuntary discharge of urine or feces.
Likert-like scale Graded self evaluation
Longitudinal taken over time, multiple data points from expression
Narcolepsy Chronic sleep disorder characterized by overwhelming daytime drowsiness and sudden attacks of sleep.
Ophthalmology: Distance visual activity (DVA): Acuteness or clearness of vision, especially form vision, which is dependent on
the sharpness of the retinal focus within the eye and the sensitivity of the interpretative faculty of the brain.
Extra-ocular movement (EOM): Can often identify abnormalities in individual muscles or in particular cranial
nerves (oculomotor, trochlear, or abducens) in their course from the brainstem to the orbit, in the brainstem
nuclei, or finally, in the higher-order centers and pathways in the cortex and brainstem that control eye
movements; an example of EOM is saccades.
Systemic lupus erythematosus (SLE): A chronic, relapsing autoimmune disease that may affect skin, joints, and
internal organs. The most common ocular finding is the presence of cotton wool spots, retinal hemorrhages,
and papilledema. Other symptoms such as lid swelling, exophthalmus, and fluctuating weakness of extraocular
muscles may occur.
Ophthalmoplegia (horizontal and vertical) A paralysis or weakness of one or more of the muscles that control eye movement. Eyes don’t move togethera `
double vision.
Psychotic Episodes Hallucinating, altered reality
Saccades Fast movement of an eye, head or other part of an animal’s body or device; eye saccades are quick,
simultaneous movements of both eyes in the same direction; serve as a mechanism for fixation, rapid eye
movement and the fast phase of optokinetic nystagmus (a type of involuntary eye movement).
Seizures A sudden episode of transient neurologic symptoms such as involuntary muscle movements, sensory
disturbances and altered consciousness.
Supranuclear Vertical Gaze Palsy Cannot look upwards, impaired upward gaze
Xanthoma A skin condition in which fat builds up under the surface of the skin; common, particularly among older adults
and persons with high blood lipids.
Also need to know: Behavior, eye movement, hearing, memory, psychiatric, speech, swallowing, respiratory problems
doi:10.1371/journal.pone.0023666.t001
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speech (the higher scoring group scored speech 1 pt higher than all
other individuals (1–2) (Figure S2). In case 5, the discrepancies in
scoring occurred in cognition (1-3) and swallow (3–5) (not shown):
Even for case 6, where there was little variation in overall scoring
(Fig. 3B and Fig. S1), there were scoring discrepancies between
cognition and memory. 1 pair consistently scored cognition 1 and
memory 3. 2 other pairs scored cognition 3 and memory 0 (not
shown). Another problem with case 7 was that it contained data
from just four visits and the main source of error appears to be
from visit 3, when pair 2 provided an anomalously high score of 21
instead of 14.5 and 15.5 (See Figures S1 and S2). Due to carry
over this resulted in continued maintenance of the elevated score
by pair 2 in visit 4. In contrast, in case 5, pair 2 appeared to
consistently score lower than pairs 1 and 3, through all ten visits
and hence the overall slope for pair 2 is closely comparable to pairs
1 and 3 (Figure S1).
In aggregate, the data in Figures 3, suggest that it is probably
desirable to have a clinical record assessed by 3-5 (rather than 2)
students to flag occasional anomalies in scoring. Moreover we
should also flag for greater scrutiny, records with (i) less than 5
visits disease curves and/or (ii) disease where cognition, memory,
fine motor skills and speech are the prominent symptoms, since the
students sometimes show a range of scores for these phenotypes.
Despite these scoring anomalies, all seven disease severity curves
mapped back with close correspondence to the progression
described by Yanjanin et al. 2010 [6] (Figs. 3 C, D).
In summary the data show that both science-majors and non
majors (but who were declared premed), can consistently be
trained to assess and quantify NPC major and minor clinical
Figure 2. Initial assessment of one NP-C patient medical record by five students in Spring 2009. A. Five students independently scored
one NP-C patient’s medical record, The disease severity curves were plotted as shown. The correlation among their evaluation is 0.76. The best fit line
is shown in black line with a slope of 1.315. In red is the best fit line (with a slope of 1.3 and a correlation of 0.90) obtained by Yanjanin et al. 2010. B.
The average of five student scores (show in blue) was overlaid on a summary of disease severity curves obtained by Yanjanin et al 2010 (obtained by
combining their historical and current cohorts). C. The progression slope shown in panels A and B was determined by linear regression and overlaid
(blue dot) onto the progression slope created by Yanjanin et al. 2010.
doi:10.1371/journal.pone.0023666.g002
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histories in a defined class structure.
Scoring and disease severity curve generated from two
new NPC patient records donated directly to our study
Two new clinical histories that were not previously assessed by
Yanjanin et al. 2010 [6] were directly donated by families to our
study in Spring 2010 and Spring 2011 respectively.
In Spring 2010, a group of four students assessed the record,
and progression of severity of disease (Figure S3) was mapped back
to the cohort group of Yanjanin et al., 2010 [6] (Fig. 4A–B).
Notably the linear regression yielded a slope of 2.676, (Fig. S3),
which was greater than three standard deviations from the mean
slope originally described by Yanjanin et al., 2010 [6] 1.960.2.
This appeared to be due to the fact that patient displayed
accelerated rapid disease progression in the last two clinical visits
recorded. For the remaining data points, the curve and
progression slope appeared to be in range (,2.2) with the other
patients previously reported by Yanjanin et al. 2010 [6].
The second case directly donated in Spring 2011 was assessed
by all 30 students in class because in addition to generating the
disease severity curve, we were also interested in investigating the
inherent variation across individual students in a larger class.
Thus, we had each of the thirty students assess the new record.
The average disease severity curve was mapped back to the cohort
of Yanjanin et al. 2010 [6] (Fig. 4A–B). The linear regression curve
yielded a slope of 2.45, again suggesting accelerated disease
progression compared to the cohort.
We therefore examined in detail the individual disease
progression curves and scores that were derived from across
clinical visits (in Figures S4 and S5). In aggregate these data
showed that approximately 3–4 (,10%) of 30 students had
Figure 3. Assessment of four NP-C patient medical records by expanded class sizes. A. Disease severity curves generated by two different
classes of sixteen students in Fall 2009 and Spring 2010. From each class groups of three to five students evaluated four NP-C patient’s medical
records obtained from Yanjanin et al. 2010. Each group evaluated one patient record. Error bars indicate scoring variation between the two classes.
Linear best fit shown as solid black line for each record. Hatched line indicates best fit obtained by Yanjanin et al 2010. Color code: case 1, blue; case
2, red; case 3, purple; case 4 green; B. Disease severity curves generated by thirty students in Spring 2011. Five groups of six students scored the four
NP-C medical records from panel A as well as three additional records. Scoring was done by pairs of students and triplicate scores were generated for
each medical record as shown. Color code as indicated in panel A as well as case 5, magenta; case 6 orange; case 7, teal. Triplicate curves associated
with each case, where each curve indicated pair wise scoring. C. The average of curves shown in panel B overlaid a summary of disease severity
curves described in Yanjanin et al. 2010. D. The progression slope shown in panel C was determined by linear regression and overlaid onto the
progression slope created by Yanjanin et al. 2010. Red arrows indicate extent of displacement of progression obtained from student assessments.
Colors as indicated for panel C. When students’ progression values were used, the progression slope was found to be 1.907 +/2 0.2374. The original
progression slope calculated by Yanjanin et al. 1.923 +/2 0.2200.
doi:10.1371/journal.pone.0023666.g003
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as 2 standard deviations away from the mode (Fig. S5). However
this bias did not change the slope, suggesting that the accelerated
disease progression portrayed was consistently observed across
operators. This was similar to the accelerated rapid disease
progression in the last two clinical visits recorded in the first
donated clinical record shown in Fig. 4A
Creation of a clinical summary sheet
For each clinical case, students also created one to two page
summary sheet displaying a history of medical visits and lab tests,
onset of major and minors systems, utilization of drugs, known
contraindication, allergies, hospitalizations, surgical procedures, all
physicians and specialists previously visited including reason for
visit, and herbal supplements. This summary provides a condensed
insight for physicians treating NPC patients and is a service
product that could be helpful to families.
Discussion
Our study suggests that college students were able to review and
assess clinical records once they achieved understanding of clinical
NPC disease manifestation, diagnosis and management and
learned the requisite medical terminology indicated and method
of scoring. One difficulty was variability and sometimes limited
information in individual medical histories. The method is
dependent on the quality of existing medical records. The records
from the NIH are equivalent to those from a university outpatient
clinical setting, with evaluation by neurologists familiar with
metabolic disorders. Records from primary care centers were also
used, although the charts from standard hospital chart-systems,
were relatively well organized since the specialist was integrated
into the same system.
In-class discussions also focused on ambiguity of scoring domains
and how to score inconsistently recorded data. After students
independently graphed the plots, it was apparent that inter-
individual variability based on ambiguity of recognizing domains
were small and that the scoring process was robust. Discussion
with clinical experts Forbes D. Porter M.D., Ph. D. and Nicole
Yanjanin N.P. provided guidelines (previously reported in
Yanjanin et al. 2010 [6]) on handling inconsistently recorded
data. In early phases of the course, direct interaction with clinical
practitioners greatly facilitated confidence in utilization and
interpretation of scoring methods and data, although the 2011
class was able to complete finals scores prior to their interaction
with clinical practitioners.
The take-home assessment of a single patient history was
completed within 6 hours of out-of-class time. Assigning a record
to three to four students per group would be sufficient to ensure
accurate and verifiable assessment. Moreover once the group is
trained (in the first four weeks), additional records could be
assessed at the rate of one per week per student pair, for the
remaining eight weeks. Finally the class size is easily scalable up to
50 students, suggesting significant, future, potential for assessing
,200 patient records in the course of one semester. Thus this
approach as the ability to produce a robust database from which
the Natural History of a rare disease could be extracted. The
limiting factor is obtaining sufficient number of records and thus
coordination with a parent support organization (PSO) would be
critical. PSOs may also be helpful to prospective studies, by
providing attending physicians with a list of questions on clinical
history and symptoms that serve as a checklist for the disorder, but
mechanisms to ensure that such a list is systematically used, are
also needed.
Assessment of the two medical records directly contributed to
our study (received in Spring 2010 and 2011) supported the model
of Yanjanin et al. (2010; 6) but also revealed, unexpected and
accelerated disease progression, especially at later stages, not
predicted by the severity scale of Yanjanin et al., 2010 [6]. One
possible explanation for this is that the current scale is based on
patients who can travel to the NIH, because travel for patients in
wheel chairs, needing oxygen and other critical assistance is
difficult. Additionally, travel to a tertiary clinical center typically
requires travel with family members and a natural history study on
Figure 4. Assessment of two new NP-C patient medical records donated directly to the study. A. Disease severity curves of medical
record donated in Spring 2010 (red) and Spring 2011 (blue). The Spring 2010 case was assessed by four students. The Spring 2011 case was assessed
by 30 students. The data were overlaid on disease severity curves obtained by Yanjanin et al., 2010. B. The progression slopes of two curves shown in
panel A were determined by linear regression and overlaid onto the progression slope created by Yanjanin et al. 2010.
doi:10.1371/journal.pone.0023666.g004
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years, further complicating logistics and increasing costs to the
point that it would be difficult to fund. This is in contrast to
relatively low costs of retrospective analysis of a decade or more of
existing medical records, by taking advantage of existing university
infrastructure and training. The Yanjanin et al study continues to
provide a reference point for the linear disease progression model,
however additional data is needed to ascertain the relative
contribution of quadratic disease progression (Table S2) and
accurately model the full disease course.
Additional review of community-based assessment of patient
records will reveal whether it can provide specific insight into the
natural history at more severe stages of disease, in addition to
accelerate the volume of assessments needed to strengthen disease
scores to assess urgently needed, emerging therapies for NPC. It
will also be of interest to determine whether community based
assessment of patient records in other rare diseases can be
undertaken to yield insights into disease processes and prognosis.
Supporting Information
Figure S1 Disease severity scores generated by pairs of
students for cases 5-7 for curves shown in Figure 3B.
(TIF)
Figure S2 Disease severity scores generated by individ-
ual students for case 7. Pair 1 Score, Pair 2 Score, and Pair 3
Score indicate student pairs and individual domain scores for a
pair is separated by a comma, as shown.
(TIF)
Figure S3 Disease severity curve for new case donated
in Spring 2010.
(TIF)
Figure S4 Individual disease severity curves for new
case donated in Spring 2011, as assessed by 30
individual students.
(TIF)
Figure S5 Individual disease severity scores for new
case donated in Spring 2011, as assessed by 30
individual students.
(TIF)
Table S1
(PDF)
Table S2 Average linear and quadratic R
2 values for
disease severity curves associated with cases 1-7
(numbered as described in Figure 3B). The suffix (Y)
indicates that they were obtained from medical records reported in
Yanjanin et al (2010). New cases donated directly to our study in
2010 and 2011, not previously reported by Yanjanin et al (2010)
and assessed in Figure 4, are also indicated. *Log fit is best fit.
(DOCX)
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